SPECTRAL AI, INC. Net Income (Loss) Allocated to General Partners
SPECTRAL AI, INC. (MDAI) reported Net Income (Loss) Allocated to General Partners of $2.15 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-31.
Discontinued › Expense Statement › Operating Expenses
us-gaap:NetIncomeLossAllocatedToGeneralPartners · last filed 2022-08-12
- SPECTRAL AI, INC. net income (loss) allocated to general partners for the quarter ending 2021-06-30 was -$2.90M.
- SPECTRAL AI, INC. net income (loss) allocated to general partners for the quarter ending 2021-03-31 was $3.22M.
- SPECTRAL AI, INC. net income (loss) allocated to general partners for fiscal 2021 was $2.15M.
| Period end | Net Income (Loss) Allocated to General Partners 1 month | Net Income (Loss) Allocated to General Partners 3 month | Net Income (Loss) Allocated to General Partners 6 month | Net Income (Loss) Allocated to General Partners 12 month |
|---|---|---|---|---|
| 2021-12-31 | $2.15M 10-K · filed 2022-03-31 | |||
| 2021-06-30 | -$2.90M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $318.97K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $3.22M 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | $675.00 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |